Considering the regulation of metabolic reprogramming in prostate cancer by SREBF1 and its relationship with ferroptosis, we investigated the effect of the SREBF1 inhibitor Betulin on promoting ferroptosis in prostate cancer. Here, SREBF1 is linked to prostate cancer.